APA (7th ed.) Citation

Antonia, S. J., Borghaei, H., Ramalingam, S. S., Horn, L., De Castro Carpeño, J., Pluzanski, A., . . . Brahmer, J. (2019). Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: A pooled analysis. Lancet Oncology, 20(10), 1395. https://doi.org/10.1016/S1470-2045(19)30407-3

Chicago Style (17th ed.) Citation

Antonia, Scott J., et al. "Four-year Survival with Nivolumab in Patients with Previously Treated Advanced Non-small-cell Lung Cancer: A Pooled Analysis." Lancet Oncology 20, no. 10 (2019): 1395. https://doi.org/10.1016/S1470-2045(19)30407-3.

MLA (9th ed.) Citation

Antonia, Scott J., et al. "Four-year Survival with Nivolumab in Patients with Previously Treated Advanced Non-small-cell Lung Cancer: A Pooled Analysis." Lancet Oncology, vol. 20, no. 10, 2019, p. 1395, https://doi.org/10.1016/S1470-2045(19)30407-3.